FRIDA THERAPEUTICS
Live / Applied — Extension of time to oppose received (as of 08 Oct 2026)
What this means for you
Not registered yet, but its 24 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99722602
- Mark type
- Word mark
- Filed
- 24 Mar 2026
- Published for opposition
- 08 Sept 2026
- Attorney of record
- Kristin H. Altoff
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development services of new pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; research and development services for the treatment of autoimmune, inflammatory, and allergic diseases
Owner
- FridaTX, Inc., Boston, MA, US
- FridaTX, Inc., Boston, MA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 99722602 — FRIDABABY, LLC v. FridaTX, Inc., filed 08 Oct 2026 (Open)
Prosecution history
- 08 Oct 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 08 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Sept 2026 — PUBLISHED FOR OPPOSITION
- 02 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Aug 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Aug 2026 — EXAMINER'S AMENDMENT ENTERED
- 12 Aug 2026 — EXAMINERS AMENDMENT E-MAILED
- 12 Aug 2026 — EXAMINERS AMENDMENT -WRITTEN
- 09 Aug 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Aug 2026 — NON-FINAL ACTION E-MAILED
- 09 Aug 2026 — NON-FINAL ACTION WRITTEN
- 05 Aug 2026 — ASSIGNED TO EXAMINER
- 29 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Mar 2026 — APPLICATION FILING RECEIPT MAILED